The recent announcement of novel, viable viruses created by artificial intelligence (AI) was celebrated as a major advance in the fight against antibiotic resistance. But it also raised urgent concerns about regulation.
Alongside precision gene-editing technologies such as CRISPR/Cas9 and synthetic biology, AI is now making it increasingly possible to design and alter entire biological systems.